BANK OF AMERICA CORP /DE/
BankPosition in RLMD — Relmada Therapeutics, Inc.
CIK 70858
CHARLOTTE, NC
Position in RLMD
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$5,619,448
+$4,742,899 QoQ
Shares Held
812,059
+544.8% QoQ
Ownership
0.761%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#29
of 126 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RLMD Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026BANK OF AMERICA CORP /DE/ holds $10,144,297,346 across 338 Biotechnology names. RLMD ranks #138 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,039,178 | $1,509,650,884 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,291,053 | $805,023,185 | |
| 3 | CYTK |
Cytokinetics Inc
|
4,635,709 | $394,916,048 | |
| 4 | ARGX |
Argenx SE
|
400,234 | $371,325,094 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
994,476 | $299,367,107 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
1,136,091 | $273,763,844 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
4,568,341 | $259,527,450 | |
| 8 | RPRX |
Royalty Pharma plc
|
4,149,422 | $232,658,090 |
All Filings in RLMD
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,619,448 | 812,059 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $876,549 | 125,941 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $122,391 | 25,340 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $528 | 263 | Shares | Defined | 2026-02-03 | |
| 2025-06-30 | $194 | 324 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $3,703 | 13,716 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $107,461 | 206,657 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $669,571 | 206,658 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $623,907 | 207,969 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $979,178 | 210,576 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $872,012 | 210,631 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $640,605 | 213,535 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $582,775 | 236,901 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $84,374 | 37,334 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $57,792 | 16,560 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $513,281 | 13,865 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $166,863 | 8,787 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $181,803 | 6,736 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $234,446 | 10,406 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $321,884 | 12,281 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $198,365 | 6,197 | Shares | Defined | 2021-09-13 | |
| 2021-03-31 | $273,861 | 7,778 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $186,262 | 5,808 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $284,368 | 7,559 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $393,844 | 8,801 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $476,243 | 13,962 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||